Home » Topics » BioWorld Science, Endocrine/metabolic

BioWorld Science, Endocrine/metabolic
RSS

Novel PPAR modulators discovered by Lilly scientists

Oct. 3, 2003

New acetyl-CoA carboxylase inhibitors identified by Pfizer researchers

Oct. 3, 2003

Oral gallium formulation reported to reach therapeutic serum levels in Paget's disease

Oct. 3, 2003

Lower incidence of fractures and improved bone quality in patients treated with risedronate

Oct. 3, 2003

Improved BMD in hypogonadal men treated with testosterone gel

Oct. 3, 2003

Dainippon and Takeda discontinue development of antidiabetic agent

Oct. 3, 2003

Cinacalcet effective in preclinical and clinical studies

Oct. 2, 2003

AMG-162 demonstrates beneficial pharmacokinetics, activity in osteoporosis

Oct. 2, 2003

Clinical evidence of teriparatide efficacy grows

Oct. 2, 2003

Combination therapy with SERMs for osteopenia

Oct. 2, 2003

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 26, 2026.
Brain-computer interfaces are here but long road ahead
BioWorld
The field of BCI is continually evolving; as such, companies are increasingly highlighting the potential of their technologies to transform care. For advanced...
ENCALS 2026: From genetics to advancing strategies against ALS
BioWorld Science
Amyotrophic lateral sclerosis (ALS)-associated genes provide direct therapeutic targets and reveal pathways that can be used to develop treatments that counteract...
Next wave of BCI firms builds on pioneers to tackle challenges
BioWorld
With the pace of neurotechnology development accelerating, a wave of brain-computer interface (BCI) companies is emerging on the heels of the pioneers. In the...
Boehringer Ingelheim identifies new mGlu3 receptor agonists
BioWorld Science
Boehringer Ingelheim Pharma GmbH & Co. KG and Vanderbilt University have discovered new dihydrobenzoxazine compounds acting as metabotropic glutamate mGlu3...